Volume 12, Issue 12, Pages (September 2015)

Slides:



Advertisements
Similar presentations
Volume 20, Issue 2, Pages (July 2017)
Advertisements

Volume 86, Issue 5, Pages (June 2015)
Volume 77, Issue 2, Pages (January 2013)
Volume 49, Issue 4, Pages (February 2006)
Michael J Beckstead, David K Grandy, Kevin Wickman, John T Williams 
Volume 79, Issue 3, Pages (August 2013)
Presynaptic Self-Depression at Developing Neocortical Synapses
Endocannabinoids Control the Induction of Cerebellar LTD
Burst-Timing-Dependent Plasticity of NMDA Receptor-Mediated Transmission in Midbrain Dopamine Neurons  Mark T. Harnett, Brian E. Bernier, Kee-Chan Ahn,
Pamela F. Marcott, Aphroditi A. Mamaligas, Christopher P. Ford  Neuron 
Activation of VTA GABA Neurons Disrupts Reward Consumption
Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid- Dependent Lipid Signaling  Stephanie C. Gantz, Bruce P. Bean  Neuron  Volume.
Suppression of Inhibitory Synaptic Potentiation by Presynaptic Activity through Postsynaptic GABAB Receptors in a Purkinje Neuron  Shin-ya Kawaguchi,
Liang Yang, Yong Qi, Yunlei Yang  Cell Reports 
Volume 45, Issue 1, Pages (January 2005)
Volume 82, Issue 6, Pages (June 2014)
Volume 34, Issue 2, Pages (April 2002)
Long-Term Depression of mGluR1 Signaling
Heterosynaptic LTD of Hippocampal GABAergic Synapses
Volume 25, Issue 3, Pages (March 2000)
Volume 86, Issue 5, Pages (June 2015)
Volume 11, Issue 12, Pages (June 2015)
Leslie R. Whitaker, Mickael Degoulet, Hitoshi Morikawa  Neuron 
Dopaminergic Modulation of Axon Initial Segment Calcium Channels Regulates Action Potential Initiation  Kevin J. Bender, Christopher P. Ford, Laurence.
Volume 77, Issue 2, Pages (January 2013)
Volume 87, Issue 6, Pages (December 1996)
Volume 23, Issue 1, Pages (April 2018)
A Cooperative Mechanism Involving Ca2+-Permeable AMPA Receptors and Retrograde Activation of GABAB Receptors in Interpeduncular Nucleus Plasticity  Peter.
Volume 68, Issue 5, Pages (December 2010)
Volume 92, Issue 2, Pages (October 2016)
Volume 16, Issue 2, Pages (July 2016)
Differential Dopamine Regulation of Ca2+ Signaling and Its Timing Dependence in the Nucleus Accumbens  Immani Swapna, Brian Bondy, Hitoshi Morikawa  Cell.
Volume 12, Issue 6, Pages (August 2015)
Huibert D Mansvelder, J.Russel Keath, Daniel S McGehee  Neuron 
Volume 22, Issue 10, Pages (March 2018)
Plasticity of Burst Firing Induced by Synergistic Activation of Metabotropic Glutamate and Acetylcholine Receptors  Shannon J. Moore, Donald C. Cooper,
Dario Brambilla, David Chapman, Robert Greene  Neuron 
Volume 31, Issue 3, Pages (August 2001)
Selectively Impaired Endocannabinoid-Dependent Long-Term Depression in the Lateral Habenula in an Animal Model of Depression  Hoyong Park, Jeehae Rhee,
Endocannabinoids Mediate Neuron-Astrocyte Communication
Manami Yamashita, Shin-ya Kawaguchi, Tetsuya Hori, Tomoyuki Takahashi 
Volume 27, Issue 3, Pages e5 (April 2019)
Cocaine Inhibition of Synaptic Transmission in the Ventral Pallidum Is Pathway-Specific and Mediated by Serotonin  Aya Matsui, Veronica A. Alvarez  Cell.
Huibert D Mansvelder, Daniel S McGehee  Neuron 
Jeffrey A. Dzubay, Thomas S. Otis  Neuron 
Stephan D. Brenowitz, Wade G. Regehr  Neuron 
Noradrenergic Control of Associative Synaptic Plasticity by Selective Modulation of Instructive Signals  Megan R. Carey, Wade G. Regehr  Neuron  Volume.
Volume 13, Issue 7, Pages (November 2015)
Adenosine and ATP Link PCO2 to Cortical Excitability via pH
Dual Dopaminergic Regulation of Corticostriatal Plasticity by Cholinergic Interneurons and Indirect Pathway Medium Spiny Neurons  Shana M. Augustin, Jessica.
Volume 125, Issue 4, Pages (May 2006)
Calcium Release from Stores Inhibits GIRK
Endogenous Cannabinoids Mediate Retrograde Signals from Depolarized Postsynaptic Neurons to Presynaptic Terminals  Takako Ohno-Shosaku, Takashi Maejima,
Serotonergic Modulation of Sensory Representation in a Central Multisensory Circuit Is Pathway Specific  Zheng-Quan Tang, Laurence O. Trussell  Cell Reports 
Stephanie Rudolph, Linda Overstreet-Wadiche, Jacques I. Wadiche  Neuron 
Kristina Valentinova, Manuel Mameli  Cell Reports 
Strong G-Protein-Mediated Inhibition of Sodium Channels
Karen M. Crosby, Wataru Inoue, Quentin J. Pittman, Jaideep S. Bains 
Volume 57, Issue 3, Pages (February 2008)
Metaplasticity of Hypothalamic Synapses following In Vivo Challenge
Spontaneous Neurotransmitter Release Shapes Dendritic Arbors via Long-Range Activation of NMDA Receptors  Laura C. Andreae, Juan Burrone  Cell Reports 
Activation of VTA GABA Neurons Disrupts Reward Consumption
Volume 17, Issue 11, Pages (December 2016)
Volume 20, Issue 2, Pages (July 2017)
Burst-Timing-Dependent Plasticity of NMDA Receptor-Mediated Transmission in Midbrain Dopamine Neurons  Mark T. Harnett, Brian E. Bernier, Kee-Chan Ahn,
Volume 57, Issue 3, Pages (February 2008)
Selectively Impaired Endocannabinoid-Dependent Long-Term Depression in the Lateral Habenula in an Animal Model of Depression  Hoyong Park, Jeehae Rhee,
Volume 57, Issue 6, Pages (March 2008)
Matthew T. Rich, Yanhua H. Huang, Mary M. Torregrossa  Cell Reports 
Volume 54, Issue 1, Pages (April 2007)
Presentation transcript:

Volume 12, Issue 12, Pages 1997-2008 (September 2015) Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area  Huikun Wang, Tyler Treadway, Daniel P. Covey, Joseph F. Cheer, Carl R. Lupica  Cell Reports  Volume 12, Issue 12, Pages 1997-2008 (September 2015) DOI: 10.1016/j.celrep.2015.08.041 Copyright © 2015 The Authors Terms and Conditions

Cell Reports 2015 12, 1997-2008DOI: (10.1016/j.celrep.2015.08.041) Copyright © 2015 The Authors Terms and Conditions

Figure 1 Tonic Inhibition of GABA Signaling in VTA DA Neurons Is Mediated by 2-AG (A) Sample traces (left) and time-courses of GABAB IPSCs (right) during CB1R ligand treatment; CB1R agonist WIN55,212-2 (WIN, 1 μM), CB1R antagonist/inverse agonist, AM251 (2 μM), and neutral antagonist PIMSR1 (2 μM). Gray traces in all figures indicate those during treatment. Gray area in time course indicates period of drug application. Scale bar, 100 ms, 10 pA. (B) Summary of CB1R ligand effects on GABAB IPSCs (F(2,14) = 30.75, p < 0.0001, one-way ANOVA, ∗p < 0.01, ∗∗p < 0.001, Tukey’s post hoc). (C) The AM251-mediated increase in GABAB IPSCs is prevented by inclusion of the DGL inhibitor, THL (5 μM), in the pipette (∗p < 0.05, unpaired t test). Scale bar, 100 ms, 10 pA. (D) The AM251-induced increase of GABAB IPSCs is enhanced by the MAG lipase inhibitor JZL184 (10 μM; ∗∗p < 0.01, unpaired t test). Scale bar, 100 ms, 10 pA. Cell Reports 2015 12, 1997-2008DOI: (10.1016/j.celrep.2015.08.041) Copyright © 2015 The Authors Terms and Conditions

Figure 2 Cocaine-Induced Increase in NAc DA Transients Require CB1R Activation in VTA (A) Voltammetric current (encoded in color) plotted against the applied carbon-fiber electrode potential (ordinate) and the acquisition time (abscissa). Traces above color plots represent current (normalized to concentration) from the potential where DA is oxidized (∼+0.6 V in green), when animals are given an i.v. bolus of cocaine (1 mg/kg), preceded by intra-VTA vehicle infusion. (B) Systemic effects of cocaine are attenuated following CB1R blockade in VTA (250 ng rimonabant [Rbt] in 500 μl, unilateral and ipsilateral to the recording electrode). (C) Effects of all treatments on NAc DA transient frequency (F(4,31) = 29.14, p < 0.0001, one-way ANOVA; n = 12 rats). Baseline indicates the frequency of DA transients without intracranial or systemic injections. In other groups the intra-VTA injection is indicated first, followed by the i.v. injection (e.g., intracranial Veh∖intra-VTA Veh). Note that Rbt alone (Rbt/Veh) did not alter DA transient frequency, and Rbt significantly reduced the effect of i.v. cocaine on DA transients (Rbt/cocaine, ∗∗∗p < 0.0001, Bonferroni post hoc test). Cell Reports 2015 12, 1997-2008DOI: (10.1016/j.celrep.2015.08.041) Copyright © 2015 The Authors Terms and Conditions

Figure 3 Cocaine-Mobilized 2-AG Inhibits GABA Release and Increases DA Release in NAc via Actions in VTA (A) Acute cocaine (10 μM) perfusion inhibited GABAB IPSCs and this was partially blocked by AM251 (2 μM). Scale bar, 100 ms, 10 pA. (B) Cocaine inhibition of GABAB IPSCs was reduced by inhibition of DGL with THL, applied either intracellularly via the pipette (intra-THL) or extracellularly, by addition to the aCSF (extra-THL). Scale bar, 100 ms, 10 pA. (C) Summary of the experiments shows significant reduction of the cocaine inhibition of GABAB IPSCs by AM251 and THL (n = 5; F(3,36) = 6.35, p = 0.0014, one-way ANOVA; ∗p < 0.05 and ∗∗p < 0.01, Bonferroni post hoc analysis). (D) Cocaine did not affect postsynaptic GABAB currents evoked by laser (indicated by vertical bar on sweeps inset) uncaging of O-CNB-Caged-GABA (100–200 μM in bath; n = 7, p > 0.05, paired t test. Scale bar, 100 ms, 10 pA. (E) In vivo NAc FSCV current (encoded in color) is plotted against the applied potential (ordinate) and the acquisition time (abscissa). Traces above color plots are extracted currents (normalized to concentration) from the potential where DA is oxidized (∼+0.6 V shown in green), when animals are given intravenous cocaine (1 mg/kg), preceded by an i.c.v. vehicle injection. (F) Effects of cocaine are reduced in vivo by inhibition of 2-AG synthesis by THL in the VTA (750 ng THL in 500 μl, unilateral and ipsilateral to the recording electrode). (G) Intra-VTA THL reduces DA transient frequency elicited by i.v. cocaine (F (4,10) = 9.395, p = 0.002, one-way ANOVA; n = 3 rats, ∗∗p < 0.001, Bonferroni post hoc analysis). Baseline indicates DA transient frequency without intracranial or systemic injections. In other groups, the intra-VTA injection is indicated first, followed by the i.v. injection condition (e.g., intracranial Veh∖intra-VTA Veh). Note that THL alone (THL/Veh) did not alter DA transient frequency, and THL significantly reduced the effect of i.v. cocaine on DA transients (THL/cocaine, p < 0.001, Bonferroni post hoc test). See also Figure S1. Cell Reports 2015 12, 1997-2008DOI: (10.1016/j.celrep.2015.08.041) Copyright © 2015 The Authors Terms and Conditions

Figure 4 Inhibition of GABAB IPSCs by Cocaine Is Independently Mediated by 5HT1B and CB1 Receptors (A) Inhibition of GABAB IPSC by cocaine was largely occluded by the 5HT1B receptor agonist sumatriptan (300 nM). (B) The selective 5HT1B receptor antagonist GR55562 (1 or 10 μM) suppressed the inhibition by cocaine. (C) The inhibition by cocaine was completely abolished when CB1 and 5HT1B receptors were blocked simultaneously. (D) Serotonin-induced depression of GABAB IPSC is independent of CB1Rs. Application of the 5HT1B agonist sumatriptan, the selective serotonin reuptake inhibitor citalopram (10 μM), or the serotonin releaser fenfluramine (10 μM) all depressed GABAB IPSCs to a similar level. However, this is unaffected by the CB1R antagonist AM251 (4 μM; F(2,46) = 0.25, p = 0.77, two-way ANOVA). Scale bar, 100 ms, 10 pA. (E) Pre-treatment with the selective DA transport inhibitor, GBR12935 (1 μM), does not occlude the inhibition of GABAB IPSCs by cocaine. (F) The DA-D2 receptor antagonist sulpiride (5 μM) does not prevent the inhibition by cocaine. (G) Summary the effect of cocaine on GABAB IPSCs with different drug treatments (F(5,51) = 12.83, p < 0.0001, one-way ANOVA; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001 versus cocaine; #p < 0.05 versus GR55562; Bonferroni post hoc analysis). The complete elimination of the cocaine-induced inhibition of GABAB IPSCs by CB1R and 5-HT1B antagonism indicates that these effects are independent. Cell Reports 2015 12, 1997-2008DOI: (10.1016/j.celrep.2015.08.041) Copyright © 2015 The Authors Terms and Conditions

Figure 5 Mobilization of 2-AG by Cocaine Requires Synergistic Activation of mGluR1 and α1 Adrenergic Receptors and Activation of Phospholipase C All experiments were performed in the presence of GR55562 to block 5-HT1B receptors. (A) Inhibition of GABAB IPSCs by cocaine was blocked by AM251 (2 μM), the mGluR1 antagonist JNJ16259685 (JNJ, 500 nM) and the α1R antagonist HEAT (1 μM) (F(3,29) = 5.173, p = 0.0055, one-way ANOVA; ∗p < 0.05, Bonferroni post hoc analysis). (B) Co-application of the mGluR1 agonist DHPG (1 μM) and the α1 agonist phenylephrine (PE, 100 μM) inhibited GABAB IPSCs, whereas alone these agonists did not exhibit such effects. Pre-incubation of slices with AM251 significantly blocked the synergistic effect of DHPG and PE (F(3,26) = 20.19, p < 0.0001, one-way ANOVA; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001, Bonferroni post hoc analysis). Scale bar, 100 ms, 10 pA. Scale bar applies to (A). (C) The NET inhibitor nisoxetine (10 μM) occluded the inhibition of GABAB IPSCs by cocaine (∗p < 0.05, unpaired t test). Scale bar, 100 ms, 10 pA. (D) An inhibitor of PLC, U73122 (5 μM), significantly blocked the effect of cocaine (∗p < 0.05 versus cocaine, unpaired t test). Scale bar, 100 ms, 10 pA. See also Figures S2 and S3. Cell Reports 2015 12, 1997-2008DOI: (10.1016/j.celrep.2015.08.041) Copyright © 2015 The Authors Terms and Conditions

Figure 6 Cocaine-Induced Calcium Changes in VTA DA Neurons (A) Superimposed fluorescent and transmitted light images showing the expression of GCaMP6f in VTA DA neurons 2–3 weeks after injection of the AAV- GCaMP6f construct. Scale bar, 500 μm. (B) Spontaneous slow calcium oscillations in VTA DA neurons. Left: confocal image of the GCaMP6f signal (200×). Scale bar, 50 μm. Right: example calcium oscillations (ΔF/F0) in the same cell indicated in the dashed square at left. Scale bar, 30 s, 20%. (C) Sample traces of calcium signals (ΔF/F0) in response to cocaine application (10 μM, indicated in gray). Three types of changes were observed: no change, a decrease in spontaneous oscillations, and the initiation of slow oscillations (SO). (D) Raster plot of oscillation events in 19 neurons imaged as in (B). Each vertical bar denotes the peak of an oscillation event. Each row exhibits the time course of oscillation change in single neurons. (E) Cumulative frequencies of spontaneous, cocaine-decreased, and cocaine-initiated slow oscillations (cocaine SO) in calcium signal. The curve shifts left to slower frequencies in neurons whose calcium oscillations were decreased by cocaine (osc decrease versus spontaneous, p = 0.17, K-S test). The frequency of cocaine-initiated SO was significantly lower than that of spontaneous oscillations (cocaine-initiated versus spontaneous, p < 0.01, K-S test). Spontaneous oscillation, n = 43 neurons; oscillation decrease, n = 19 neurons; cocaine SO, n = 29 neurons recorded in eight brain slices from six rats. (F) Cumulative distribution of half-widths of spontaneous, cocaine-decreased, and cocaine-initiated SO. Cocaine-initiated SO exhibit longer half-widths than spontaneous oscillations. (cocaine SO versus spontaneous, p < 0.0001, K-S test). Spontaneous oscillation, n = 43 neurons; oscillation decrease, n = 19 neurons; cocaine SO, n = 29 neurons recorded in eight brain slices from six rats. (G) Increased correlation of calcium responses among neurons (same 19 neurons as D) during cocaine perfusion. Cross correlations among all neuron pairs were calculated, and the peak correlation coefficient (r = 0 to 1) is color-coded to form the heat map. The data indicate that VTA DA neuron calcium oscillations are more highly synchronized by cocaine. (H) Cocaine-induced calcium oscillations depend on mGluR1, α1-adrenergic receptors, and internal calcium stores. The frequency of spontaneous calcium oscillations is reduced by JNJ16259685 (500 nM), but is not altered by HEAT (1 μM), U73122, or thapsigargin (thaps, 2 μM), respectively (F(4,265) = 3.806, p = 0.005, one-way ANOVA; control versus JNJ: p < 0.05, Bonferroni post hoc analysis). Each point represents the frequency of spontaneous Ca2+ oscillation from one neuron; the box and vertical lines indicate quartiles, minimal, and maximal frequencies. The percentage of neurons exhibiting spontaneous oscillations is shown for each treatment group. (I) Cumulative distributions of the frequencies of spontaneous oscillations are only affected by JNJ (p = 0.0037, Kolmogorov–Smirnov test). (J) Summary of the percentage of DA neurons responding to cocaine under control, JNJ16259685, HEAT, U73122, and thapsigargin treatments. Numbers denote the percentage of neurons demonstrating indicated changes upon cocaine treatment. All treatments decreased the cocaine-induced Ca2+ oscillation. (K) Pre-treatment of slices with thapsigargin (2 μM) significantly attenuates the inhibition of GABAB IPSCs by cocaine (n = 7; ∗p < 0.05, unpaired t test). Inset at right shows averaged electrically evoked GABAB IPSC traces (n = 5) under control conditions (top) and after treatment with thapsigargin. Control sweeps are shown in black; those obtained during cocaine application are shown in gray. Scale bar, 100 ms, 10 pA. See also Movie S1. Cell Reports 2015 12, 1997-2008DOI: (10.1016/j.celrep.2015.08.041) Copyright © 2015 The Authors Terms and Conditions

Figure 7 Putative Mechanism of Cocaine Mobilization of 2-AG and Inhibition of GABA Neurotransmission in the VTA Glutamate spillover under baseline conditions activates mGluR1s, and α1-adrenergic receptors located on VTA DA neurons are activated by NE whose clearance is prevented by cocaine blockade of the NET. This co-activation of Gq11-coupled mGluR1 and α1Rs cooperatively stimulates PLC-β leading to DAG formation. DAG is then converted to 2-AG, via DGL-α, then crosses the extracellular space through an unknown mechanism to activate CB1Rs located on GABA axon terminals. Activation of these presynaptic CB1Rs inhibits GABA release onto postsynaptic GABAB receptors, leading to 2-AG-mediated disinhibition of DA neurons. This increases DA transients in the NAc to enhance the rewarding properties of cocaine. Cell Reports 2015 12, 1997-2008DOI: (10.1016/j.celrep.2015.08.041) Copyright © 2015 The Authors Terms and Conditions